Reduction of inappropriate dosing-- testing a real-time prescriber decision support tool
1. The Health Outcome (s) include: Primary: prevalence of dosing in agreement with FDA package labelling (dose, frequency, with and without food; route, contraindications medication interactions); Secondary: if not in agreement, documentation of reasons for deviation from FDA package labelling; and post study: Exploratory: prescriber satisfaction with point of care decision support.